Investing.com - Longeveron LLC reported on Monday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Longeveron LLC announced earnings per share of $-0.250 on revenue of $300K. Analysts polled by Investing.com anticipated EPS of $-0.220 on revenue of $200K.
Longeveron LLC shares are down 67% from the beginning of the year, still down 91.31% from its 52 week high of $45.00 set on November 24, 2021.
Longeveron LLC shares lost 7.93% in pre-market trade following the report.
Longeveron LLC follows other major Healthcare sector earnings this month
Longeveron LLC's report follows an earnings beat by J&J on October 18, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on November 1 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar